ow volume contrast dye for CT chest and abdomen angiography
Phase 1
- Conditions
- Health Condition 1: I00-I99- Diseases of the circulatory system
- Registration Number
- CTRI/2019/07/020192
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients referred for CT Aortic Angiography with age from 30-80 years
Exclusion Criteria
Patients with endovascular stenting, unco-operative patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CTDI vol (mGy) <br/ ><br>DLP- Dose Length Product (mGy.cm) <br/ ><br>Effective dose (mSv)Timepoint: CTDI vol (mGy)will be noted - 6 months <br/ ><br>DLP- Dose Length Product - 6 months (mGy.cm) <br/ ><br>Effective dose (mSv)
- Secondary Outcome Measures
Name Time Method Subjective and Objective image quality <br/ ><br>Assessment <br/ ><br>Timepoint: Subjective and Objective image quality <br/ ><br>Assessment - weekly one time